Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/28253225 below:

Cancer Screening Test Use - United States, 2015

• PMID: 28253225
• PMCID: PMC5657895
• DOI: 10.15585/mmwr.mm6608a1

Item in Clipboard

Arica White et al. MMWR Morb Mortal Wkly Rep. 2017.

Healthy People 2020 (HP2020) includes objectives to increase screening for breast, cervical, and colorectal cancer (1) as recommended by the U.S. Preventive Services Task Force (USPSTF).* Progress toward meeting these objectives is monitored by measuring cancer screening test use against national targets using data from the National Health Interview Survey (NHIS) (1). Analysis of 2015 NHIS data indicated that screening test use remains substantially below HP2020 targets for selected cancer screening tests. Although colorectal cancer screening test use increased from 2000 to 2015, no improvements in test use were observed for breast and cervical cancer screening. Disparities exist in screening test use by race/ethnicity, socioeconomic status, and health care access indicators. Increased measures to implement evidence-based interventions and conduct targeted outreach are needed if the HP2020 targets for cancer screening are to be achieved and the disparities in screening test use are to be reduced.

PubMed Disclaimer

Percentage of adults who were up…

Percentage of adults who were up to date with screening for breast, cervical, and…

Percentage of adults who were up to date with screening for breast, cervical, and colorectal cancers, by test, sex, and year — United States, 2000–2015. Abbreviation: CRC = colorectal cancer. * The U.S. Preventive Services Task Force (USPSTF) recommends mammography within 2 years for women aged 50–74 years. ^† USPSTF recommends Papanicolaou (Pap) test within 3 years for women aged 21–65 years without hysterectomy, or Pap test with human papillomavirus test within 5 years for women aged 30–65 years without hysterectomy. To account for changing screening recommendations over time for cervical cancer for women aged 21–65 years without hysterectomy, only trends for Pap test within 3 years for women aged 21–65 years without hysterectomy were assessed; Pap test data for 2003 are missing. ^§ The USPSTF recommends three options for CRC screening: 1) fecal occult blood test within 1 year; 2) sigmoidoscopy within 5 years and fecal occult blood test within3 years; or 3) colonoscopy within 10 years for respondents aged 50–75 years.

• Cancer screening test use - United States, 2013.

  Sabatino SA, White MC, Thompson TD, Klabunde CN; Centers for Disease Control and Prevention (CDC). Sabatino SA, et al. MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):464-8. MMWR Morb Mortal Wkly Rep. 2015. PMID: 25950253 Free PMC article.

• Perceived Financial Barriers to Cervical Cancer Screening and Associated Cost Burden Among Low-Income, Under-Screened Women.

  Biddell CB, Spees LP, Smith JS, Brewer NT, Des Marais AC, Sanusi BO, Hudgens MG, Barclay L, Jackson S, Kent EE, Wheeler SB. Biddell CB, et al. J Womens Health (Larchmt). 2021 Sep;30(9):1243-1252. doi: 10.1089/jwh.2020.8807. Epub 2021 Apr 13. J Womens Health (Larchmt). 2021. PMID: 33851854 Free PMC article.

• Patient navigator reported patient barriers and delivered activities in two large federally-funded cancer screening programs.

  Barrington WE, DeGroff A, Melillo S, Vu T, Cole A, Escoffery C, Askelson N, Seegmiller L, Gonzalez SK, Hannon P. Barrington WE, et al. Prev Med. 2019 Dec;129S:105858. doi: 10.1016/j.ypmed.2019.105858. Epub 2019 Oct 22. Prev Med. 2019. PMID: 31647956 Free PMC article.

1. 1. Office of Disease Prevention and Health Promotion. Healthy people 2020. Washington, DC: US Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 2017. https://www.healthypeople.gov
2. 1. National Center for Health Statistics. National Health Interview Survey, 2015. Hyattsville, Maryland: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2016.
3. 1. Sabatino SA, White MC, Thompson TD, Klabunde CN. Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:464–8. - PMC - PubMed
4. 1. Joseph DA, Redwood D, DeGroff A, Butler EL. Use of evidence-based interventions to address disparities in colorectal cancer screening. MMWR Suppl 2016;65(Suppl 1):21–8. 10.15585/mmwr.su6501a5 - DOI - PubMed
5. 1. White A, Richardson LC, Li C, Ekwueme DU, Kaur JS. Breast cancer mortality among American Indian and Alaska Native women, 1990–2009. Am J Public Health 2014;104(Suppl 3):S432–8. 10.2105/AJPH.2013.301720 - DOI - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3